| Principal Name | Title | Start Date |
|---|---|---|
| Georgianne Valli-Harwood, MD | A research study evaluating stress test protocols for patients with known or suspected CAD who cannot complete full exercise tests. | 07/30/2012 |
| Daniel Doyle, MD | A study to Evaluate the effect of Roflumilast(Daliresp), on the exacerbation rate in patients with COPD | 03/25/2013 |
| Harvey Zimbler, MD | B-43 - A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma in Situ Resected by Lumpectomy | 11/10/2008 |
| Harvey Zimbler, MD | B-47 - A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High Risk N ode-Negative HER2-Low Invasive Breast Cancer | |
| Harvey Zimbler, MD | B-49 - "A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer" | 03/09/2012 |
| Harvey Zimbler, MD | CALGB 90203 " A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prosatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer" | |
| Harvey Zimbler, MD | E1305 - "A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer" | |
| Harvey Zimbler, MD | N1048: " A Phase II/III Trial of Neoadjuvant FOLFOX with Sellective Use of Combined Modality Chemoradiation vs Preop Combined Modality Chemoradiation for Locally Adv Rectal Cancer Patients Undergoing Low Ant Resection with Total Mesorectal Excisio | 10/03/2012 |
| Harvey Zimbler, MD | RTOG 0815- A Phase III Prospective Randomized Trial of Dose-escalated Radiotherapy With or Without Short-Term and Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer" | |
| Harvey Zimbler, MD | RTOG 0848- " A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma" | |
| Harvey ZImbler, MD | RTOG 1005 - " A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boostr Versus Standard Whole Breast Irradiaiton Plus Sequential Boost for Early-Stage Breast Cancer" | |
| Harvey Zimbler, MD | RTOG 1010 - " A Phase III Trial Evaluating the Addition of Trastuzumab To Trimodallity Treatment of HER2-Overespressing Esophageal Adenocarcinoma | |
| Harvey Zimbler, MD | S0819 - " A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients with Advanced Non-Small Cel Lung Cancer (NSCLC) | |
| Harvey ZImbler, MD | S1007 - " A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients iwth 1-3 Postiive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score of 25 or less" | |
| Timothy Counihan, MD | Study to Prevent Incisional Infections among Colorectal Surgery Patients with a new Topical Solution | 03/01/2013 |
© 2019 Berkshire Health Systems
725 North Street
Pittsfield, MA 01201